3.9 Article

Knockout of PKCα enhances insulin signaling through PI3K

Journal

MOLECULAR ENDOCRINOLOGY
Volume 16, Issue 4, Pages 847-858

Publisher

OXFORD UNIV PRESS INC
DOI: 10.1210/me.16.4.847

Keywords

-

Funding

  1. NIDDK NIH HHS [R01 DK065969, R01-DK-38079-11] Funding Source: Medline

Ask authors/readers for more resources

Insulin stimulates glucose transport and certain other metabolic processes by activating atypical PKC isoforms (lambda, zeta, iota) and protein kinase B (PKB) through increases in D3-polyphosphoinositides derived from the action of PI3K. The role of diacylglycerol-sensitive PKC isoforms is less clear as they have been suggested to be both activated by insulin and yet inhibit insulin signaling to PI3K. Presently, we found that insulin signaling to insulin receptor substrate 1-dependent PI3K, PKB, and PKClambda, and downstream processes, glucose transport and activation of ERK, were enhanced in skeletal muscles and adipocytes of mice in which the ubiquitous conventional diacylglycerol-sensitive PKC isoform, PKCalpha, was knocked out by homologous recombination. On the other hand, insulin provoked wortmannin-insensitive increases in immunoprecipitable PKCalpha activity in adipocytes and skeletal muscles of wild-type mice and rats. We conclude that 1) PKCalpha is not required for insulin-stimulated glucose transport, and 2) PKCalpha is activated by insulin at least partly independently of PI3K, and largely serves as a physiological feedback inhibitor of insulin signaling to the insulin receptor substrate 1/PI3K/PKB/PKClambda/zeta/iota complex and dependent metabolic processes.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available